Research programme: anti-FLT-1 monoclonal antibody - BioWa
Alternative Names: BIW 8556; FLT-1 monoclonal antibody; KM 2550Latest Information Update: 05 Nov 2023
At a glance
- Originator BioWa
- Class Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Vascular endothelial growth factor receptor-1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 29 May 2007 Preclinical development is ongoing
- 17 May 2005 This compound is still in active development - (BioSquare-2005)
- 03 Mar 2004 Anti-FLT-1 monoclonal antibody is available for licensing in Europe, North America and South America (http://www.biowa.com)